At 6.5% CAGR, Asia Pacific Non-Invasive Ventilation Masks Market is Projected to be Worth US$ 719.68 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific non-invasive ventilation masks market was valued at US$ 433.81 million in 2023 and is expected to reach US$ 719.68 million by 2031, registering a CAGR of 6.5% from 2023 to 2031. Increasing adoption of NIV masks and growing inclination towards home healthcare are among the critical factors attributed to drive the Asia Pacific non-invasive ventilation masks market growth.

A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in a better, consistent, and timely interaction between patient and doctor owing to the cloud and mobility-driven medical devices. The COVID-19 outbreak triggered home healthcare's importance due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. With the help of home healthcare, healthcare professionals can monitor patient's vitals remotely and avoid hospital admissions. Moreover, patients with conditions such as COPD, sleep apnea, and other respiratory issues are increasingly expressing a preference for at-home management of their ailments. Patients can use NIV therapy in the comfort of their homes without having to make frequent visits to the hospital. Home healthcare providers are prescribing NIV masks more frequently as a component of all-encompassing respiratory care plans. Therefore, due to the growing traction toward home healthcare and increasing demand for more advanced, affordable, and easily navigable devices at home, the market for Noninvasive ventilation masks is gaining noticeable traction.

On the contrary, side effects associated with NIV masks hamper the growth of Asia Pacific non-invasive ventilation masks market.

By product, the Asia Pacific non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held 60.9% share of Asia Pacific non-invasive ventilation masks market share in 2023, amassing US$ 264.17 million. It is projected to garner US$ 427.36 million by 2031 to register 6.2% CAGR during 2023–2031.

In terms of application, the Asia Pacific non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held 54.2% share of Asia Pacific non-invasive ventilation masks market share in 2023, amassing US$ 235.32 million. It is projected to garner US$ 396.22 million by 2031 to register 6.7% CAGR during 2023–2031.

Based on end user, the Asia Pacific non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held 50.7% share of Asia Pacific non-invasive ventilation masks market share in 2023, amassing US$ 220.08 million. It is projected to garner US$ 372.26 million by 2031 to register 6.8% CAGR during 2023–2031.

Based on country, the Asia Pacific non-invasive ventilation masks market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 26.3% share of Asia Pacific non-invasive ventilation masks market in 2023. It was assessed at US$ 114.14 million in 2023 and is likely to hit US$ 197.37 million by 2031, registering a CAGR of 7.1% during 2023–2031.

Key players operating in the non-invasive ventilation masks market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD.; among others.

• In May 2022: Air Liquide Healthcare launched ALNEST N1 Silent mask. Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices (vented) for adult patients (weighing more than 30 kg) undergoing non-invasive positive pressure ventilation therapy (NPPV) like CPAP or BiPAP.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com